Differential Effects of Tautomycetin and Its Derivatives on Protein Phosphatase Inhibition, Immunosuppressive Function and Antitumor Activity |
Niu, Mingshan
(Research Center for Molecular Medicine, Dalian University of Technology)
Sun, Yan (Research Center for Molecular Medicine, Dalian University of Technology) Liu, Bo (Research Center for Molecular Medicine, Dalian University of Technology) Tang, Li (Research Center for Molecular Medicine, Dalian University of Technology) Qiu, Rongguo (Research Center for Molecular Medicine, Dalian University of Technology) |
1 | Bollen M. Combinatorial control of protein phosphatase-1. Trends Biochem Sci. 2001;26:426-431. DOI ScienceOn |
2 | Cohen PT. Protein phosphatase 1--targeted in many directions. J Cell Sci. 2002;115:241-256. |
3 | Heneberg P. Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs. Curr Med Chem. 2009;16:706-733. DOI ScienceOn |
4 | Shim JH, Lee HK, Chang EJ, Chae WJ, Han JH, Han DJ, Morio T, Yang JJ, Bothwell A, Lee SK. Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction. Proc Natl Acad Sci USA. 2002;99:10617-10622. DOI ScienceOn |
5 | Lee JH, Lee JS, Kim SE, Moon BS, Kim YC, Lee SK, Lee SK, Choi KY. Tautomycetin inhibits growth of colorectal cancer cells through p21cip/WAF1 induction via the extracellular signal-regulated kinase pathway. Mol Cancer Ther. 2006;5:3222-3231. DOI ScienceOn |
6 | Lee SH, Hahn SJ, Min G, Kim J, Jo SH, Choe H, Choi BH. Inhibitory actions of HERG currents by the immunosuppressant drug cyclosporin A. Korean J Physiol Pharmacol. 2011;15:291-297. DOI ScienceOn |
7 | Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell. 1992;69:1227-1236. DOI ScienceOn |
8 | Gust B, Challis GL, Fowler K, Kieser T, Chater KF. PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc Natl Acad Sci USA. 2003;100:1541-1546. DOI ScienceOn |
9 | Van Gompel JJ, Kunnimalaiyaan M, Holen K, Chen H. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Mol Cancer Ther. 2005;4:910-917. DOI ScienceOn |
10 | Yan Y, Mumby MC. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2a regulates the activities of G(1) cyclin-dependent kinases. J Biol Chem. 1999;274:31917-31924. DOI |
11 | Kawamura T, Matsuzawa S, Mizuno Y, Kikuchi K, Oikawa H, Oikawa M, Ubukata M, Ichihara A. Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis. Biochem Pharmacol. 1998;55:995-1003. DOI ScienceOn |
12 | Matsuzawa S, Kawamura T, Mitsuhashi S, Suzuki T, Matsuo Y, Suzuki M, Mizuno Y, Kikuchi K. Thyrsiferyl 23-acetate and its derivatives induce apoptosis in various T- and B-leukemia cells. Bioorg Med Chem. 1999;7:381-387. DOI ScienceOn |
13 | Liu S, Yu Z, Yu X, Huang SX, Luo Y, Wu L, Shen W, Yang Z, Wang L, Gunawan AM, Chan RJ, Shen B, Zhang ZY. SHP2 is a target of the immunosuppressant tautomycetin. Chem Biol. 2011;18:101-110. DOI ScienceOn |
14 | Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D, Hartshorne DJ. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun. 1989;159:871-877. DOI ScienceOn |
15 | Egloff MP, Johnson DF, Moorhead G, Cohen PT, Cohen P, Barford D. Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J. 1997;16:1876-1887. DOI ScienceOn |
16 | Cheng XC, Kihara T, Ying X, Uramoto M, Osada H, Kusakabe H, Wang BN, Kobayashi Y, Ko K, Yamaguchi I, Shen YC, Isono K. A new antibiotic, tautomycetin. J Antibiot (Tokyo). 1989;42:141-144. DOI |
17 | Mitsuhashi S, Matsuura N, Ubukata M, Oikawa H, Shima H, Kikuchi K. Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. Biochem Biophys Res Commun. 2001;287:328-331. DOI ScienceOn |
18 | Li YM, Casida JE. Cantharidin-binding protein: identification as protein phosphatase 2A. Proc Natl Acad Sci USA. 1992;89:11867-11870. DOI ScienceOn |
19 | Roberge M, Tudan C, Hung SM, Harder KW, Jirik FR, Anderson H. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A. Cancer Res. 1994;54:6115-6121. |
20 | Nishiwaki-Matsushima R, Nishiwaki S, Ohta T, Yoshizawa S, Suganuma M, Harada K, Watanabe MF, Fujiki H. Structurefunction relationships of microcystins, liver tumor promoters, in interaction with protein phosphatase. Jpn J Cancer Res. 1991;82:993-996. DOI |
21 | Pearson L, Mihali T, Moffitt M, Kellmann R, Neilan B. On the chemistry, toxicology and genetics of the cyanobacterial toxins, microcystin, nodularin, saxitoxin and cylindrospermopsin. Mar Drugs. 2010;8:1650-1680. DOI ScienceOn |